Corrigendum to Management of immune-related adverse events under PD-1/PD-L1 inhibitors: Insights from a Moroccan real-world experience

Cancer Treatment and Research Communications 2026 Open access

Read full text
Authors: Inès Cherradi, Mohamed Ichou, Mohammed Sqalli Houssaïni, Nabil Ismaili
DOI: 10.1016/j.ctarc.2026.101104
Cited by: 0

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Pharmacovigilance and Adverse Drug Reactions Immunotherapy and Immune Responses

Publication details

Journal / source
Cancer Treatment and Research Communications
Volume
46
Pages
101104–101104
Publication date
1 January 2026
Language
EN